Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Cancer Res. 2010 Mar 9;70(6):2445–2454. doi: 10.1158/0008-5472.CAN-09-2468

Figure 5.

Figure 5

A. Anchorage-independent growth and colony formation in MDA-MB-231 breast cancer cells is impaired by FLLL31 and FLLL32. B. The invasive capacity of MDA-MB-231 breast cancer cells is reduced to a greater extent by FLLL31 and FLLL32 than curcumin. C. FLLL31 or D. FLLL32 exhibits synergy with doxorubicin (Doxo) in growth suppression of MDA-MB-231 breast cancer cells.